BRINZOLAMIDA TEVA 10mg / ml ophthalmic drops suspension medication leaflet

S01EC04 brinzolamide • Sensory organs | Antiglaucoma preparations and miotics | Carbonic anhydrase inhibitors

Brinzolamidum is a medication used to reduce elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. It is a carbonic anhydrase inhibitor that decreases the production of intraocular fluid, thereby lowering pressure inside the eye.

The medication is administered as eye drops, usually two or three times a day, as directed by a doctor. It is important for patients to follow the treatment regimen to prevent vision deterioration.

Common side effects include a burning or stinging sensation in the eyes, temporary blurred vision, and a bitter taste in the mouth. In rare cases, allergic reactions or severe dry eyes may occur.

Brinzolamidum is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about any other conditions or medications being used to avoid drug interactions.

General data about BRINZOLAMIDA TEVA 10mg / ml

Substance: brinzolamide

Date of last drug list: 01-10-2015

Commercial code: W61853002

Concentration: 10mg / ml

Pharmaceutical form: ophthalmic drops suspension

Quantity: 3

Product type: generic

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Other substances similar to brinzolamide